nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Tetany—Furosemide—dilated cardiomyopathy	0.0657	0.0726	CcSEcCtD
Flumazenil—Ataxia—Spironolactone—dilated cardiomyopathy	0.0269	0.0297	CcSEcCtD
Flumazenil—Injection site pain—Furosemide—dilated cardiomyopathy	0.0262	0.029	CcSEcCtD
Flumazenil—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0225	0.0249	CcSEcCtD
Flumazenil—Drowsiness—Spironolactone—dilated cardiomyopathy	0.022	0.0243	CcSEcCtD
Flumazenil—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.018	0.0198	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0178	0.0197	CcSEcCtD
Flumazenil—Deafness—Furosemide—dilated cardiomyopathy	0.0174	0.0192	CcSEcCtD
Flumazenil—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0161	0.0178	CcSEcCtD
Flumazenil—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.016	0.0176	CcSEcCtD
Flumazenil—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0156	0.0172	CcSEcCtD
Flumazenil—Malaise—Spironolactone—dilated cardiomyopathy	0.0155	0.0172	CcSEcCtD
Flumazenil—Discomfort—Spironolactone—dilated cardiomyopathy	0.0145	0.016	CcSEcCtD
Flumazenil—Confusional state—Spironolactone—dilated cardiomyopathy	0.0142	0.0157	CcSEcCtD
Flumazenil—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0128	0.0142	CcSEcCtD
Flumazenil—Somnolence—Spironolactone—dilated cardiomyopathy	0.0125	0.0138	CcSEcCtD
Flumazenil—Drowsiness—Furosemide—dilated cardiomyopathy	0.012	0.0132	CcSEcCtD
Flumazenil—Diplopia—Lisinopril—dilated cardiomyopathy	0.0117	0.0129	CcSEcCtD
Flumazenil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0116	0.0128	CcSEcCtD
Flumazenil—Sweating—Furosemide—dilated cardiomyopathy	0.0115	0.0127	CcSEcCtD
Flumazenil—Urticaria—Spironolactone—dilated cardiomyopathy	0.0112	0.0123	CcSEcCtD
Flumazenil—Ataxia—Lisinopril—dilated cardiomyopathy	0.011	0.0121	CcSEcCtD
Flumazenil—Visual impairment—Furosemide—dilated cardiomyopathy	0.0104	0.0115	CcSEcCtD
Flumazenil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0104	0.0114	CcSEcCtD
Flumazenil—Tinnitus—Furosemide—dilated cardiomyopathy	0.01	0.0111	CcSEcCtD
Flumazenil—Pruritus—Spironolactone—dilated cardiomyopathy	0.00994	0.011	CcSEcCtD
Flumazenil—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00982	0.0109	CcSEcCtD
Flumazenil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00961	0.0106	CcSEcCtD
Flumazenil—Erythema—Furosemide—dilated cardiomyopathy	0.00937	0.0103	CcSEcCtD
Flumazenil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00929	0.0103	CcSEcCtD
Flumazenil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00893	0.00987	CcSEcCtD
Flumazenil—Rash—Spironolactone—dilated cardiomyopathy	0.00886	0.00979	CcSEcCtD
Flumazenil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00885	0.00978	CcSEcCtD
Flumazenil—Vision blurred—Furosemide—dilated cardiomyopathy	0.00883	0.00975	CcSEcCtD
Flumazenil—Headache—Spironolactone—dilated cardiomyopathy	0.0088	0.00972	CcSEcCtD
Flumazenil—Sweating—Lisinopril—dilated cardiomyopathy	0.00862	0.00952	CcSEcCtD
Flumazenil—Agitation—Furosemide—dilated cardiomyopathy	0.00861	0.00951	CcSEcCtD
Flumazenil—Vertigo—Furosemide—dilated cardiomyopathy	0.00842	0.0093	CcSEcCtD
Flumazenil—Nausea—Spironolactone—dilated cardiomyopathy	0.00835	0.00922	CcSEcCtD
Flumazenil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00822	0.00908	CcSEcCtD
Flumazenil—Hallucination—Lisinopril—dilated cardiomyopathy	0.00803	0.00887	CcSEcCtD
Flumazenil—Dry mouth—Furosemide—dilated cardiomyopathy	0.0078	0.00862	CcSEcCtD
Flumazenil—Confusional state—Furosemide—dilated cardiomyopathy	0.00771	0.00852	CcSEcCtD
Flumazenil—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00753	0.00832	CcSEcCtD
Flumazenil—Flushing—Lisinopril—dilated cardiomyopathy	0.00749	0.00828	CcSEcCtD
Flumazenil—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00739	0.00816	CcSEcCtD
Flumazenil—Chills—Lisinopril—dilated cardiomyopathy	0.00724	0.008	CcSEcCtD
Flumazenil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00721	0.00797	CcSEcCtD
Flumazenil—Hypotension—Furosemide—dilated cardiomyopathy	0.00714	0.00789	CcSEcCtD
Flumazenil—Erythema—Lisinopril—dilated cardiomyopathy	0.00703	0.00776	CcSEcCtD
Flumazenil—Tension—Lisinopril—dilated cardiomyopathy	0.0069	0.00762	CcSEcCtD
Flumazenil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00686	0.00758	CcSEcCtD
Flumazenil—Nervousness—Lisinopril—dilated cardiomyopathy	0.00683	0.00754	CcSEcCtD
Flumazenil—Somnolence—Furosemide—dilated cardiomyopathy	0.0068	0.00751	CcSEcCtD
Flumazenil—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00662	0.00732	CcSEcCtD
Flumazenil—Fatigue—Furosemide—dilated cardiomyopathy	0.00659	0.00728	CcSEcCtD
Flumazenil—Tremor—Lisinopril—dilated cardiomyopathy	0.00658	0.00727	CcSEcCtD
Flumazenil—Pain—Furosemide—dilated cardiomyopathy	0.00654	0.00722	CcSEcCtD
Flumazenil—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00652	0.0072	CcSEcCtD
Flumazenil—Malaise—Lisinopril—dilated cardiomyopathy	0.00634	0.007	CcSEcCtD
Flumazenil—Vertigo—Lisinopril—dilated cardiomyopathy	0.00631	0.00698	CcSEcCtD
Flumazenil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0063	0.00696	CcSEcCtD
Flumazenil—Palpitations—Lisinopril—dilated cardiomyopathy	0.00621	0.00686	CcSEcCtD
Flumazenil—Cough—Lisinopril—dilated cardiomyopathy	0.00613	0.00678	CcSEcCtD
Flumazenil—Urticaria—Furosemide—dilated cardiomyopathy	0.00607	0.00671	CcSEcCtD
Flumazenil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00598	0.00661	CcSEcCtD
Flumazenil—Anxiety—Lisinopril—dilated cardiomyopathy	0.00596	0.00659	CcSEcCtD
Flumazenil—Discomfort—Lisinopril—dilated cardiomyopathy	0.00591	0.00653	CcSEcCtD
Flumazenil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00585	0.00646	CcSEcCtD
Flumazenil—Confusional state—Lisinopril—dilated cardiomyopathy	0.00578	0.00639	CcSEcCtD
Flumazenil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00563	0.00622	CcSEcCtD
Flumazenil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0056	0.00618	CcSEcCtD
Flumazenil—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00554	0.00613	CcSEcCtD
Flumazenil—Asthenia—Furosemide—dilated cardiomyopathy	0.00548	0.00606	CcSEcCtD
Flumazenil—Pruritus—Furosemide—dilated cardiomyopathy	0.00541	0.00597	CcSEcCtD
Flumazenil—Hypotension—Lisinopril—dilated cardiomyopathy	0.00536	0.00592	CcSEcCtD
Flumazenil—Insomnia—Lisinopril—dilated cardiomyopathy	0.00519	0.00573	CcSEcCtD
Flumazenil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00515	0.00569	CcSEcCtD
Flumazenil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00511	0.00565	CcSEcCtD
Flumazenil—Somnolence—Lisinopril—dilated cardiomyopathy	0.0051	0.00563	CcSEcCtD
Flumazenil—Dizziness—Furosemide—dilated cardiomyopathy	0.00505	0.00558	CcSEcCtD
Flumazenil—Fatigue—Lisinopril—dilated cardiomyopathy	0.00494	0.00546	CcSEcCtD
Flumazenil—Pain—Lisinopril—dilated cardiomyopathy	0.0049	0.00542	CcSEcCtD
Flumazenil—Vomiting—Furosemide—dilated cardiomyopathy	0.00486	0.00537	CcSEcCtD
Flumazenil—Rash—Furosemide—dilated cardiomyopathy	0.00482	0.00532	CcSEcCtD
Flumazenil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00482	0.00532	CcSEcCtD
Flumazenil—Headache—Furosemide—dilated cardiomyopathy	0.00479	0.00529	CcSEcCtD
Flumazenil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00473	0.00522	CcSEcCtD
Flumazenil—Urticaria—Lisinopril—dilated cardiomyopathy	0.00456	0.00503	CcSEcCtD
Flumazenil—Nausea—Furosemide—dilated cardiomyopathy	0.00454	0.00502	CcSEcCtD
Flumazenil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00423	0.00467	CcSEcCtD
Flumazenil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00412	0.00455	CcSEcCtD
Flumazenil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00406	0.00448	CcSEcCtD
Flumazenil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00379	0.00419	CcSEcCtD
Flumazenil—Vomiting—Lisinopril—dilated cardiomyopathy	0.00365	0.00403	CcSEcCtD
Flumazenil—Rash—Lisinopril—dilated cardiomyopathy	0.00362	0.004	CcSEcCtD
Flumazenil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00361	0.00399	CcSEcCtD
Flumazenil—Headache—Lisinopril—dilated cardiomyopathy	0.00359	0.00397	CcSEcCtD
Flumazenil—Nausea—Lisinopril—dilated cardiomyopathy	0.00341	0.00376	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00192	0.0203	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00184	0.0194	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00182	0.0192	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00179	0.0189	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00179	0.0189	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00177	0.0187	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00177	0.0186	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00161	0.017	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00158	0.0167	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00157	0.0166	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00157	0.0166	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00156	0.0164	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00155	0.0163	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00154	0.0163	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00154	0.0163	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00152	0.016	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00152	0.016	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00152	0.016	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00151	0.0159	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00151	0.0159	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00148	0.0156	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00148	0.0156	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00137	0.0144	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00135	0.0142	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00133	0.014	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00133	0.014	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00129	0.0136	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00129	0.0136	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00118	0.0125	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00116	0.0122	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00114	0.012	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00113	0.012	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00111	0.0117	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00108	0.0114	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00106	0.0112	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00103	0.0109	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00102	0.0107	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000973	0.0103	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.000945	0.00996	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000928	0.00978	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000912	0.00961	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.000906	0.00955	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000906	0.00955	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00089	0.00938	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00089	0.00938	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000874	0.00922	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000868	0.00916	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000853	0.00899	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000777	0.0082	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000745	0.00786	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00064	0.00675	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000632	0.00667	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000623	0.00657	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000623	0.00657	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000615	0.00648	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000615	0.00648	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000579	0.00611	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000572	0.00603	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000562	0.00592	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00056	0.0059	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000552	0.00582	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000546	0.00576	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000546	0.00576	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000542	0.00572	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000539	0.00568	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000537	0.00566	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000537	0.00566	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000534	0.00563	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000529	0.00558	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000527	0.00556	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000527	0.00556	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000524	0.00552	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000524	0.00552	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000514	0.00542	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000514	0.00542	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000508	0.00536	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000506	0.00533	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000499	0.00526	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00049	0.00517	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000487	0.00514	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000478	0.00504	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000463	0.00489	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000462	0.00487	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00045	0.00474	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00045	0.00474	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000418	0.00441	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000408	0.0043	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000403	0.00425	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000363	0.00383	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000358	0.00378	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000358	0.00377	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000351	0.0037	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000345	0.00364	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000343	0.00362	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000337	0.00355	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000335	0.00354	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000318	0.00336	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000313	0.0033	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000307	0.00324	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000307	0.00323	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000305	0.00322	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000303	0.00319	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.0003	0.00316	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000294	0.0031	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000269	0.00284	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000264	0.00278	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000262	0.00276	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00026	0.00274	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000258	0.00272	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000253	0.00267	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000235	0.00248	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000232	0.00245	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000221	0.00233	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000206	0.00217	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000202	0.00213	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000199	0.0021	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000198	0.00208	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000194	0.00205	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000176	0.00186	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.00017	0.00179	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000126	0.00133	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000125	0.00131	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000111	0.00117	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000109	0.00115	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000107	0.00113	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000106	0.00112	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000104	0.0011	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.12e-05	0.000961	CbGpPWpGaD
